Documentos relacionados

1. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
2. Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms.
3. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
4. Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany.
5. Hepatic artery thrombosis and use of anticoagulants and antiplatelet agents in pediatric liver transplantation.
6. Benign prostatic hyperplasia wound after surgical removal in subjects on anticoagulant or antiplatelet therapy: A meta-analysis.
7. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
8. [Current use of oral anticoagulation therapy and influencing factors among coronary artery disease patients with nonvalvular atrial fibrillation in China].
9. [Fine-tuning of antithrombotic therapy in patients with non-valvular atrial fibrillation. The AFINVA register].
10. Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data.